nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—CYP2E1—Dacarbazine—pancreatic cancer	0.159	0.303	CbGbCtD
Felbamate—CYP2E1—Tamoxifen—pancreatic cancer	0.126	0.241	CbGbCtD
Felbamate—CYP2C19—Tamoxifen—pancreatic cancer	0.0792	0.151	CbGbCtD
Felbamate—CYP3A4—Tamoxifen—pancreatic cancer	0.0383	0.0731	CbGbCtD
Felbamate—CYP3A4—Erlotinib—pancreatic cancer	0.0325	0.0622	CbGbCtD
Felbamate—CYP3A4—Irinotecan—pancreatic cancer	0.0294	0.0561	CbGbCtD
Felbamate—CYP3A4—Docetaxel—pancreatic cancer	0.0215	0.0411	CbGbCtD
Felbamate—CYP3A4—Sunitinib—pancreatic cancer	0.0214	0.041	CbGbCtD
Felbamate—CYP3A4—Doxorubicin—pancreatic cancer	0.0161	0.0307	CbGbCtD
Felbamate—Pain—Fluorouracil—pancreatic cancer	0.000273	0.000572	CcSEcCtD
Felbamate—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000272	0.000571	CcSEcCtD
Felbamate—Dehydration—Doxorubicin—pancreatic cancer	0.000272	0.00057	CcSEcCtD
Felbamate—Eosinophilia—Epirubicin—pancreatic cancer	0.00027	0.000567	CcSEcCtD
Felbamate—Pancreatitis—Epirubicin—pancreatic cancer	0.000267	0.000561	CcSEcCtD
Felbamate—Dizziness—Sunitinib—pancreatic cancer	0.000267	0.000561	CcSEcCtD
Felbamate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000267	0.000561	CcSEcCtD
Felbamate—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000266	0.000558	CcSEcCtD
Felbamate—Body temperature increased—Irinotecan—pancreatic cancer	0.000263	0.000552	CcSEcCtD
Felbamate—Abdominal pain—Irinotecan—pancreatic cancer	0.000263	0.000552	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000263	0.000552	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000263	0.000552	CcSEcCtD
Felbamate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000263	0.000551	CcSEcCtD
Felbamate—Anaemia—Docetaxel—pancreatic cancer	0.00026	0.000547	CcSEcCtD
Felbamate—Pancytopenia—Epirubicin—pancreatic cancer	0.000259	0.000544	CcSEcCtD
Felbamate—Gastritis—Doxorubicin—pancreatic cancer	0.000258	0.000542	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000258	0.000541	CcSEcCtD
Felbamate—Muscular weakness—Doxorubicin—pancreatic cancer	0.000258	0.000541	CcSEcCtD
Felbamate—Vomiting—Sunitinib—pancreatic cancer	0.000257	0.000539	CcSEcCtD
Felbamate—Body temperature increased—Gemcitabine—pancreatic cancer	0.000256	0.000538	CcSEcCtD
Felbamate—Dysuria—Epirubicin—pancreatic cancer	0.000255	0.000535	CcSEcCtD
Felbamate—Rash—Sunitinib—pancreatic cancer	0.000255	0.000534	CcSEcCtD
Felbamate—Dermatitis—Sunitinib—pancreatic cancer	0.000254	0.000534	CcSEcCtD
Felbamate—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000254	0.000532	CcSEcCtD
Felbamate—Urticaria—Fluorouracil—pancreatic cancer	0.000253	0.000531	CcSEcCtD
Felbamate—Headache—Sunitinib—pancreatic cancer	0.000253	0.000531	CcSEcCtD
Felbamate—Asthma—Doxorubicin—pancreatic cancer	0.000252	0.00053	CcSEcCtD
Felbamate—Dysphagia—Doxorubicin—pancreatic cancer	0.000252	0.00053	CcSEcCtD
Felbamate—Leukopenia—Docetaxel—pancreatic cancer	0.000252	0.000529	CcSEcCtD
Felbamate—Body temperature increased—Fluorouracil—pancreatic cancer	0.000252	0.000529	CcSEcCtD
Felbamate—Eosinophilia—Doxorubicin—pancreatic cancer	0.00025	0.000524	CcSEcCtD
Felbamate—Palpitations—Docetaxel—pancreatic cancer	0.000249	0.000523	CcSEcCtD
Felbamate—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000249	0.000523	CcSEcCtD
Felbamate—Weight increased—Epirubicin—pancreatic cancer	0.000248	0.000521	CcSEcCtD
Felbamate—Pancreatitis—Doxorubicin—pancreatic cancer	0.000247	0.000519	CcSEcCtD
Felbamate—Weight decreased—Epirubicin—pancreatic cancer	0.000247	0.000518	CcSEcCtD
Felbamate—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000246	0.000516	CcSEcCtD
Felbamate—Cough—Docetaxel—pancreatic cancer	0.000246	0.000516	CcSEcCtD
Felbamate—Pneumonia—Epirubicin—pancreatic cancer	0.000245	0.000513	CcSEcCtD
Felbamate—Hypertension—Docetaxel—pancreatic cancer	0.000243	0.000511	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000241	0.000506	CcSEcCtD
Felbamate—Arthralgia—Docetaxel—pancreatic cancer	0.00024	0.000504	CcSEcCtD
Felbamate—Myalgia—Docetaxel—pancreatic cancer	0.00024	0.000504	CcSEcCtD
Felbamate—Chest pain—Docetaxel—pancreatic cancer	0.00024	0.000504	CcSEcCtD
Felbamate—Nausea—Sunitinib—pancreatic cancer	0.00024	0.000504	CcSEcCtD
Felbamate—Pancytopenia—Doxorubicin—pancreatic cancer	0.00024	0.000503	CcSEcCtD
Felbamate—Asthenia—Irinotecan—pancreatic cancer	0.000239	0.000501	CcSEcCtD
Felbamate—Jaundice—Epirubicin—pancreatic cancer	0.000237	0.000498	CcSEcCtD
Felbamate—Conjunctivitis—Epirubicin—pancreatic cancer	0.000236	0.000496	CcSEcCtD
Felbamate—Urinary tract infection—Epirubicin—pancreatic cancer	0.000236	0.000496	CcSEcCtD
Felbamate—Dysuria—Doxorubicin—pancreatic cancer	0.000236	0.000495	CcSEcCtD
Felbamate—Dry mouth—Docetaxel—pancreatic cancer	0.000235	0.000492	CcSEcCtD
Felbamate—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000235	0.000492	CcSEcCtD
Felbamate—Sweating—Epirubicin—pancreatic cancer	0.000233	0.000489	CcSEcCtD
Felbamate—Asthenia—Gemcitabine—pancreatic cancer	0.000233	0.000488	CcSEcCtD
Felbamate—Haematuria—Epirubicin—pancreatic cancer	0.000232	0.000487	CcSEcCtD
Felbamate—Confusional state—Docetaxel—pancreatic cancer	0.000232	0.000487	CcSEcCtD
Felbamate—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00023	0.000484	CcSEcCtD
Felbamate—Oedema—Docetaxel—pancreatic cancer	0.00023	0.000483	CcSEcCtD
Felbamate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00023	0.000483	CcSEcCtD
Felbamate—Weight increased—Doxorubicin—pancreatic cancer	0.00023	0.000482	CcSEcCtD
Felbamate—Epistaxis—Epirubicin—pancreatic cancer	0.000229	0.000481	CcSEcCtD
Felbamate—Pruritus—Gemcitabine—pancreatic cancer	0.000229	0.000481	CcSEcCtD
Felbamate—Infection—Docetaxel—pancreatic cancer	0.000228	0.00048	CcSEcCtD
Felbamate—Weight decreased—Doxorubicin—pancreatic cancer	0.000228	0.000479	CcSEcCtD
Felbamate—Sinusitis—Epirubicin—pancreatic cancer	0.000228	0.000479	CcSEcCtD
Felbamate—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000228	0.000478	CcSEcCtD
Felbamate—Diarrhoea—Irinotecan—pancreatic cancer	0.000228	0.000478	CcSEcCtD
Felbamate—Agranulocytosis—Epirubicin—pancreatic cancer	0.000227	0.000476	CcSEcCtD
Felbamate—Pneumonia—Doxorubicin—pancreatic cancer	0.000226	0.000475	CcSEcCtD
Felbamate—Pruritus—Fluorouracil—pancreatic cancer	0.000225	0.000473	CcSEcCtD
Felbamate—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000225	0.000473	CcSEcCtD
Felbamate—Tachycardia—Docetaxel—pancreatic cancer	0.000224	0.000471	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000223	0.000468	CcSEcCtD
Felbamate—Bradycardia—Epirubicin—pancreatic cancer	0.000222	0.000467	CcSEcCtD
Felbamate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000222	0.000465	CcSEcCtD
Felbamate—Dizziness—Irinotecan—pancreatic cancer	0.00022	0.000462	CcSEcCtD
Felbamate—Haemoglobin—Epirubicin—pancreatic cancer	0.000219	0.000461	CcSEcCtD
Felbamate—Jaundice—Doxorubicin—pancreatic cancer	0.000219	0.00046	CcSEcCtD
Felbamate—Anorexia—Docetaxel—pancreatic cancer	0.000219	0.00046	CcSEcCtD
Felbamate—Rhinitis—Epirubicin—pancreatic cancer	0.000219	0.000459	CcSEcCtD
Felbamate—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000219	0.000459	CcSEcCtD
Felbamate—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000219	0.000459	CcSEcCtD
Felbamate—Haemorrhage—Epirubicin—pancreatic cancer	0.000218	0.000458	CcSEcCtD
Felbamate—Hepatitis—Epirubicin—pancreatic cancer	0.000218	0.000458	CcSEcCtD
Felbamate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000218	0.000458	CcSEcCtD
Felbamate—Pharyngitis—Epirubicin—pancreatic cancer	0.000217	0.000455	CcSEcCtD
Felbamate—Sweating—Doxorubicin—pancreatic cancer	0.000216	0.000453	CcSEcCtD
Felbamate—Hypotension—Docetaxel—pancreatic cancer	0.000215	0.000451	CcSEcCtD
Felbamate—Haematuria—Doxorubicin—pancreatic cancer	0.000215	0.00045	CcSEcCtD
Felbamate—Epistaxis—Doxorubicin—pancreatic cancer	0.000212	0.000446	CcSEcCtD
Felbamate—Vomiting—Irinotecan—pancreatic cancer	0.000212	0.000444	CcSEcCtD
Felbamate—Sinusitis—Doxorubicin—pancreatic cancer	0.000211	0.000443	CcSEcCtD
Felbamate—Dizziness—Fluorouracil—pancreatic cancer	0.000211	0.000442	CcSEcCtD
Felbamate—Visual impairment—Epirubicin—pancreatic cancer	0.00021	0.000442	CcSEcCtD
Felbamate—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00021	0.000441	CcSEcCtD
Felbamate—Rash—Irinotecan—pancreatic cancer	0.00021	0.00044	CcSEcCtD
Felbamate—Dermatitis—Irinotecan—pancreatic cancer	0.00021	0.00044	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00021	0.00044	CcSEcCtD
Felbamate—Headache—Irinotecan—pancreatic cancer	0.000208	0.000437	CcSEcCtD
Felbamate—Insomnia—Docetaxel—pancreatic cancer	0.000208	0.000437	CcSEcCtD
Felbamate—Paraesthesia—Docetaxel—pancreatic cancer	0.000207	0.000433	CcSEcCtD
Felbamate—Erythema multiforme—Epirubicin—pancreatic cancer	0.000206	0.000433	CcSEcCtD
Felbamate—Vomiting—Gemcitabine—pancreatic cancer	0.000206	0.000432	CcSEcCtD
Felbamate—Bradycardia—Doxorubicin—pancreatic cancer	0.000206	0.000432	CcSEcCtD
Felbamate—Dyspnoea—Docetaxel—pancreatic cancer	0.000205	0.00043	CcSEcCtD
Felbamate—Somnolence—Docetaxel—pancreatic cancer	0.000204	0.000429	CcSEcCtD
Felbamate—Rash—Gemcitabine—pancreatic cancer	0.000204	0.000429	CcSEcCtD
Felbamate—Dermatitis—Gemcitabine—pancreatic cancer	0.000204	0.000428	CcSEcCtD
Felbamate—Haemoglobin—Doxorubicin—pancreatic cancer	0.000203	0.000426	CcSEcCtD
Felbamate—Headache—Gemcitabine—pancreatic cancer	0.000203	0.000426	CcSEcCtD
Felbamate—Flushing—Epirubicin—pancreatic cancer	0.000203	0.000425	CcSEcCtD
Felbamate—Vomiting—Fluorouracil—pancreatic cancer	0.000203	0.000425	CcSEcCtD
Felbamate—Rhinitis—Doxorubicin—pancreatic cancer	0.000203	0.000425	CcSEcCtD
Felbamate—Dyspepsia—Docetaxel—pancreatic cancer	0.000202	0.000425	CcSEcCtD
Felbamate—Haemorrhage—Doxorubicin—pancreatic cancer	0.000202	0.000424	CcSEcCtD
Felbamate—Hepatitis—Doxorubicin—pancreatic cancer	0.000202	0.000424	CcSEcCtD
Felbamate—Rash—Fluorouracil—pancreatic cancer	0.000201	0.000422	CcSEcCtD
Felbamate—Dermatitis—Fluorouracil—pancreatic cancer	0.000201	0.000421	CcSEcCtD
Felbamate—Pharyngitis—Doxorubicin—pancreatic cancer	0.000201	0.000421	CcSEcCtD
Felbamate—Decreased appetite—Docetaxel—pancreatic cancer	0.0002	0.00042	CcSEcCtD
Felbamate—Headache—Fluorouracil—pancreatic cancer	0.0002	0.000419	CcSEcCtD
Felbamate—Fatigue—Docetaxel—pancreatic cancer	0.000198	0.000416	CcSEcCtD
Felbamate—Nausea—Irinotecan—pancreatic cancer	0.000198	0.000415	CcSEcCtD
Felbamate—Constipation—Docetaxel—pancreatic cancer	0.000197	0.000413	CcSEcCtD
Felbamate—Pain—Docetaxel—pancreatic cancer	0.000197	0.000413	CcSEcCtD
Felbamate—Chills—Epirubicin—pancreatic cancer	0.000196	0.000411	CcSEcCtD
Felbamate—Visual impairment—Doxorubicin—pancreatic cancer	0.000195	0.000409	CcSEcCtD
Felbamate—Alopecia—Epirubicin—pancreatic cancer	0.000193	0.000405	CcSEcCtD
Felbamate—Nausea—Gemcitabine—pancreatic cancer	0.000193	0.000404	CcSEcCtD
Felbamate—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000191	0.000401	CcSEcCtD
Felbamate—Feeling abnormal—Docetaxel—pancreatic cancer	0.00019	0.000398	CcSEcCtD
Felbamate—Nausea—Fluorouracil—pancreatic cancer	0.000189	0.000397	CcSEcCtD
Felbamate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000188	0.000395	CcSEcCtD
Felbamate—Flushing—Doxorubicin—pancreatic cancer	0.000188	0.000394	CcSEcCtD
Felbamate—Flatulence—Epirubicin—pancreatic cancer	0.000187	0.000393	CcSEcCtD
Felbamate—Tension—Epirubicin—pancreatic cancer	0.000187	0.000391	CcSEcCtD
Felbamate—Dysgeusia—Epirubicin—pancreatic cancer	0.000186	0.000391	CcSEcCtD
Felbamate—Nervousness—Epirubicin—pancreatic cancer	0.000185	0.000387	CcSEcCtD
Felbamate—Abdominal pain—Docetaxel—pancreatic cancer	0.000182	0.000382	CcSEcCtD
Felbamate—Body temperature increased—Docetaxel—pancreatic cancer	0.000182	0.000382	CcSEcCtD
Felbamate—Chills—Doxorubicin—pancreatic cancer	0.000181	0.00038	CcSEcCtD
Felbamate—Alopecia—Doxorubicin—pancreatic cancer	0.000179	0.000375	CcSEcCtD
Felbamate—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000176	0.00037	CcSEcCtD
Felbamate—Anaemia—Epirubicin—pancreatic cancer	0.000176	0.000369	CcSEcCtD
Felbamate—Agitation—Epirubicin—pancreatic cancer	0.000175	0.000367	CcSEcCtD
Felbamate—Flatulence—Doxorubicin—pancreatic cancer	0.000173	0.000364	CcSEcCtD
Felbamate—Tension—Doxorubicin—pancreatic cancer	0.000173	0.000362	CcSEcCtD
Felbamate—Dysgeusia—Doxorubicin—pancreatic cancer	0.000172	0.000361	CcSEcCtD
Felbamate—Malaise—Epirubicin—pancreatic cancer	0.000171	0.00036	CcSEcCtD
Felbamate—Nervousness—Doxorubicin—pancreatic cancer	0.000171	0.000358	CcSEcCtD
Felbamate—Leukopenia—Epirubicin—pancreatic cancer	0.00017	0.000357	CcSEcCtD
Felbamate—Palpitations—Epirubicin—pancreatic cancer	0.000168	0.000353	CcSEcCtD
Felbamate—Cough—Epirubicin—pancreatic cancer	0.000166	0.000348	CcSEcCtD
Felbamate—Asthenia—Docetaxel—pancreatic cancer	0.000165	0.000346	CcSEcCtD
Felbamate—Hypertension—Epirubicin—pancreatic cancer	0.000164	0.000344	CcSEcCtD
Felbamate—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000163	0.000342	CcSEcCtD
Felbamate—Pruritus—Docetaxel—pancreatic cancer	0.000163	0.000341	CcSEcCtD
Felbamate—Anaemia—Doxorubicin—pancreatic cancer	0.000163	0.000341	CcSEcCtD
Felbamate—Chest pain—Epirubicin—pancreatic cancer	0.000162	0.00034	CcSEcCtD
Felbamate—Myalgia—Epirubicin—pancreatic cancer	0.000162	0.00034	CcSEcCtD
Felbamate—Arthralgia—Epirubicin—pancreatic cancer	0.000162	0.00034	CcSEcCtD
Felbamate—Agitation—Doxorubicin—pancreatic cancer	0.000162	0.000339	CcSEcCtD
Felbamate—Anxiety—Epirubicin—pancreatic cancer	0.000161	0.000338	CcSEcCtD
Felbamate—Discomfort—Epirubicin—pancreatic cancer	0.00016	0.000336	CcSEcCtD
Felbamate—Malaise—Doxorubicin—pancreatic cancer	0.000159	0.000333	CcSEcCtD
Felbamate—Dry mouth—Epirubicin—pancreatic cancer	0.000158	0.000332	CcSEcCtD
Felbamate—Leukopenia—Doxorubicin—pancreatic cancer	0.000157	0.00033	CcSEcCtD
Felbamate—Diarrhoea—Docetaxel—pancreatic cancer	0.000157	0.00033	CcSEcCtD
Felbamate—Confusional state—Epirubicin—pancreatic cancer	0.000156	0.000328	CcSEcCtD
Felbamate—Palpitations—Doxorubicin—pancreatic cancer	0.000155	0.000326	CcSEcCtD
Felbamate—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000155	0.000326	CcSEcCtD
Felbamate—Oedema—Epirubicin—pancreatic cancer	0.000155	0.000326	CcSEcCtD
Felbamate—Infection—Epirubicin—pancreatic cancer	0.000154	0.000323	CcSEcCtD
Felbamate—Cough—Doxorubicin—pancreatic cancer	0.000153	0.000322	CcSEcCtD
Felbamate—Dizziness—Docetaxel—pancreatic cancer	0.000152	0.000319	CcSEcCtD
Felbamate—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000152	0.000319	CcSEcCtD
Felbamate—Hypertension—Doxorubicin—pancreatic cancer	0.000152	0.000319	CcSEcCtD
Felbamate—Tachycardia—Epirubicin—pancreatic cancer	0.000151	0.000318	CcSEcCtD
Felbamate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00015	0.000315	CcSEcCtD
Felbamate—Chest pain—Doxorubicin—pancreatic cancer	0.00015	0.000314	CcSEcCtD
Felbamate—Arthralgia—Doxorubicin—pancreatic cancer	0.00015	0.000314	CcSEcCtD
Felbamate—Myalgia—Doxorubicin—pancreatic cancer	0.00015	0.000314	CcSEcCtD
Felbamate—Anxiety—Doxorubicin—pancreatic cancer	0.000149	0.000313	CcSEcCtD
Felbamate—Discomfort—Doxorubicin—pancreatic cancer	0.000148	0.00031	CcSEcCtD
Felbamate—Anorexia—Epirubicin—pancreatic cancer	0.000148	0.00031	CcSEcCtD
Felbamate—Dry mouth—Doxorubicin—pancreatic cancer	0.000146	0.000307	CcSEcCtD
Felbamate—Vomiting—Docetaxel—pancreatic cancer	0.000146	0.000307	CcSEcCtD
Felbamate—Rash—Docetaxel—pancreatic cancer	0.000145	0.000304	CcSEcCtD
Felbamate—Hypotension—Epirubicin—pancreatic cancer	0.000145	0.000304	CcSEcCtD
Felbamate—Dermatitis—Docetaxel—pancreatic cancer	0.000145	0.000304	CcSEcCtD
Felbamate—Confusional state—Doxorubicin—pancreatic cancer	0.000145	0.000304	CcSEcCtD
Felbamate—Headache—Docetaxel—pancreatic cancer	0.000144	0.000302	CcSEcCtD
Felbamate—Oedema—Doxorubicin—pancreatic cancer	0.000144	0.000301	CcSEcCtD
Felbamate—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000144	0.000301	CcSEcCtD
Felbamate—Infection—Doxorubicin—pancreatic cancer	0.000143	0.000299	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000141	0.000297	CcSEcCtD
Felbamate—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000141	0.000295	CcSEcCtD
Felbamate—Insomnia—Epirubicin—pancreatic cancer	0.00014	0.000294	CcSEcCtD
Felbamate—Tachycardia—Doxorubicin—pancreatic cancer	0.00014	0.000294	CcSEcCtD
Felbamate—Paraesthesia—Epirubicin—pancreatic cancer	0.000139	0.000292	CcSEcCtD
Felbamate—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000139	0.000291	CcSEcCtD
Felbamate—Dyspnoea—Epirubicin—pancreatic cancer	0.000138	0.00029	CcSEcCtD
Felbamate—Somnolence—Epirubicin—pancreatic cancer	0.000138	0.000289	CcSEcCtD
Felbamate—Anorexia—Doxorubicin—pancreatic cancer	0.000137	0.000287	CcSEcCtD
Felbamate—Nausea—Docetaxel—pancreatic cancer	0.000137	0.000287	CcSEcCtD
Felbamate—Dyspepsia—Epirubicin—pancreatic cancer	0.000137	0.000287	CcSEcCtD
Felbamate—Decreased appetite—Epirubicin—pancreatic cancer	0.000135	0.000283	CcSEcCtD
Felbamate—Hypotension—Doxorubicin—pancreatic cancer	0.000134	0.000281	CcSEcCtD
Felbamate—Fatigue—Epirubicin—pancreatic cancer	0.000134	0.000281	CcSEcCtD
Felbamate—Constipation—Epirubicin—pancreatic cancer	0.000133	0.000278	CcSEcCtD
Felbamate—Pain—Epirubicin—pancreatic cancer	0.000133	0.000278	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000131	0.000274	CcSEcCtD
Felbamate—Insomnia—Doxorubicin—pancreatic cancer	0.00013	0.000272	CcSEcCtD
Felbamate—Paraesthesia—Doxorubicin—pancreatic cancer	0.000129	0.00027	CcSEcCtD
Felbamate—Dyspnoea—Doxorubicin—pancreatic cancer	0.000128	0.000269	CcSEcCtD
Felbamate—Feeling abnormal—Epirubicin—pancreatic cancer	0.000128	0.000268	CcSEcCtD
Felbamate—Somnolence—Doxorubicin—pancreatic cancer	0.000128	0.000268	CcSEcCtD
Felbamate—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000127	0.000266	CcSEcCtD
Felbamate—Dyspepsia—Doxorubicin—pancreatic cancer	0.000126	0.000265	CcSEcCtD
Felbamate—Decreased appetite—Doxorubicin—pancreatic cancer	0.000125	0.000262	CcSEcCtD
Felbamate—Fatigue—Doxorubicin—pancreatic cancer	0.000124	0.00026	CcSEcCtD
Felbamate—Urticaria—Epirubicin—pancreatic cancer	0.000123	0.000259	CcSEcCtD
Felbamate—Constipation—Doxorubicin—pancreatic cancer	0.000123	0.000258	CcSEcCtD
Felbamate—Pain—Doxorubicin—pancreatic cancer	0.000123	0.000258	CcSEcCtD
Felbamate—Abdominal pain—Epirubicin—pancreatic cancer	0.000123	0.000257	CcSEcCtD
Felbamate—Body temperature increased—Epirubicin—pancreatic cancer	0.000123	0.000257	CcSEcCtD
Felbamate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000118	0.000248	CcSEcCtD
Felbamate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000117	0.000246	CcSEcCtD
Felbamate—Urticaria—Doxorubicin—pancreatic cancer	0.000114	0.000239	CcSEcCtD
Felbamate—Body temperature increased—Doxorubicin—pancreatic cancer	0.000113	0.000238	CcSEcCtD
Felbamate—Abdominal pain—Doxorubicin—pancreatic cancer	0.000113	0.000238	CcSEcCtD
Felbamate—Asthenia—Epirubicin—pancreatic cancer	0.000111	0.000234	CcSEcCtD
Felbamate—Pruritus—Epirubicin—pancreatic cancer	0.00011	0.00023	CcSEcCtD
Felbamate—Diarrhoea—Epirubicin—pancreatic cancer	0.000106	0.000223	CcSEcCtD
Felbamate—Asthenia—Doxorubicin—pancreatic cancer	0.000103	0.000216	CcSEcCtD
Felbamate—Dizziness—Epirubicin—pancreatic cancer	0.000103	0.000215	CcSEcCtD
Felbamate—Pruritus—Doxorubicin—pancreatic cancer	0.000102	0.000213	CcSEcCtD
Felbamate—Vomiting—Epirubicin—pancreatic cancer	9.86e-05	0.000207	CcSEcCtD
Felbamate—Diarrhoea—Doxorubicin—pancreatic cancer	9.82e-05	0.000206	CcSEcCtD
Felbamate—Rash—Epirubicin—pancreatic cancer	9.78e-05	0.000205	CcSEcCtD
Felbamate—Dermatitis—Epirubicin—pancreatic cancer	9.77e-05	0.000205	CcSEcCtD
Felbamate—Headache—Epirubicin—pancreatic cancer	9.72e-05	0.000204	CcSEcCtD
Felbamate—Dizziness—Doxorubicin—pancreatic cancer	9.49e-05	0.000199	CcSEcCtD
Felbamate—Nausea—Epirubicin—pancreatic cancer	9.21e-05	0.000193	CcSEcCtD
Felbamate—Vomiting—Doxorubicin—pancreatic cancer	9.13e-05	0.000192	CcSEcCtD
Felbamate—Rash—Doxorubicin—pancreatic cancer	9.05e-05	0.00019	CcSEcCtD
Felbamate—Dermatitis—Doxorubicin—pancreatic cancer	9.04e-05	0.00019	CcSEcCtD
Felbamate—Headache—Doxorubicin—pancreatic cancer	8.99e-05	0.000189	CcSEcCtD
Felbamate—Nausea—Doxorubicin—pancreatic cancer	8.53e-05	0.000179	CcSEcCtD
